Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1)
Stopped The study was terminated early based on the results of the planned interim analysis.
Conditions
Interventions
- DRUG: Ruxolitinib
- DRUG: Placebo
- DRUG: Capecitabine
Sponsor
Incyte Corporation